EUCTR2014-002228-28-IT进行中(未招募)1 期
A double blind, placebo controlled, parallel groups, multicenter study on filgrastim in amyotrophic lateral sclerosis - STEMALS-II
niversità degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino0 个研究点目标入组 90 人开始时间: 2014年6月12日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a. patients with definite, probable, probable laboratory-supported or possible ALS
- •b. age 20-75 years;
- •c. disease duration <=24 months;
- •d. respiratory function (FVC) = 65% of expected;
- •e. patients must understand and accept the protocol requirements, and must give a written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 90
排除标准
- •a. previous polio infection ;
- •b. motor neuron diseases other than ALS (progressive bulbar palsy , progressive muscular atrophy , primary lateral sclerosis );
- •c. clinical involvement of other neurological systems (sensory, extrapyramidal , oculomotor, cerebellar);
- •d. serious clinical conditions such as cardiovascular disease, uncontrolled hypertension, renal or hepatic impairment , dysthyroidism , Respiratory Distress Syndrome (ARDS) , sickle-cell anaemia;
- •e. subjects who have participated in any drug trial within 12 weeks prior to recruitment;
- •f . concomitant malignancy, present or past, with the exception of different melanoma skin cancers and carcinoma in situ of the cervix;
- •g . patients with severe congenital neutropaenia syndrome with abnormal cytogenetics;
- •h . patients with rare hereditary problems of fructose intolerance;
- •i . present or past malignant myeloproliferative diseases, secondary polycythemia, splenomegaly with a diameter> 14 cm, thrombophilia was found;
- •j . presence of percutaneous gastrostomy at the time of recruitment ;
- •k . presence of NIV at the time of recruitment;
- •l. subjects who have participated in any drug trial within 12 weeks prior to recruitment;
- •n . drug addiction , alcoholism, or psychiatric disorders;
- •o . women who are pregnant or breastfeeding.
研究者
相似试验
尚未招募
不适用
Clinical investigation on effects of FSFW0121 on appetite and weight management in overweight/obese subjects.CTRI/2021/12/038615Akay Natural Ingredients Pvt Ltd
进行中(未招募)
不适用
A double blind, placebo controlled, parallel group study with an open label reference arm to assess the effects of intravenously administered AIN457 on ozone induced neutrophilia compared to placebo and oral corticosteroid in healthy volunteersHealthy volunteersEUCTR2008-002854-39-DEovartis Pharma Services AG24
进行中(未招募)
不适用
A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and Cialis compared to placebo in adult male subjects with erectile dysfunction. - N/AMale Erectile DysfunctionEUCTR2004-001955-12-DEPfizer Pharma GmbH335
尚未招募
不适用
A clinical study to evaluate the safety and efficacy of VISPO in healthy subjects.CTRI/2021/12/038621Vidya Herbs Pvt Ltd
进行中(未招募)
1 期
A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and Cialis compared to placebo in adult male subjects with erectile dysfunction. - N/AMale Erectile DysfunctionEUCTR2004-001955-12-ESpfizer s.a335
